Nurix Therapeutics legal chief sells $149k in shares

it.investing.com (Italian)

Christine Ring, Chief Legal Officer of Nurix Therapeutics, sold 5,787 shares on September 2, 2026, totaling $149,072, with prices ranging from $25.41 to $26.73 per share. The sales were executed under a pre-arranged Rule 10b5-1 trading plan. Ring also acquired 5,787 shares by exercising employee stock options at $8.72 per share, costing $50,462, with options vesting monthly through February 2027. She now directly holds 9,110 shares. Nurix stock has gained 173% over the past year, trading at $25.82, near its 52-week high. Recent analyst upgrades followed a Roche collaboration, with price targets ranging from $33 to $38.


With a significance score of 1.1, this news ranks in the top 58% of today's 33724 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Nurix Therapeutics legal chief sells $149k in shares | News Minimalist